1nKemia IUCT Group (IKM) Stock Overview

Provides research and development, and technological services to chemical, pharmaceutical, biotechnological, cosmetic, nutraceutical, and related industries. More details

IKM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (€8M)

Shares are highly illiquid

IKM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,653 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

436,653 investors already sharing narratives

View all narratives

1nKemia IUCT Group, S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for 1nKemia IUCT Group
Historical stock prices
Current Share Price	€0.31
52 Week High	€0
52 Week Low	€0
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-63.10%

Recent updates

Shareholder Returns

	IKM	ES Biotechs	ES Market
7D	0%	-2.4%	-0.5%
1Y	0%	16.0%	26.0%

Return vs Industry: IKM exceeded the Spanish Biotechs industry which returned -2.6% over the past year.

Return vs Market: IKM underperformed the Spanish Market which returned 25.2% over the past year.

Price Volatility

Is IKM's price volatile compared to industry and market?
IKM volatility
IKM Average Weekly Movement	n/a
Biotechs Industry Average Movement	6.8%
Market Average Movement	2.9%
10% most volatile stocks in ES Market	6.0%
10% least volatile stocks in ES Market	0.5%

Stable Share Price: IKM's share price has been volatile over the past 3 months compared to the Spanish market.

Volatility Over Time: Insufficient data to determine IKM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1997	n/a	Josep Castells Boliart	www.inkemia.com

1nKemia IUCT Group, S.A. provides research and development, and technological services to chemical, pharmaceutical, biotechnological, cosmetic, nutraceutical, and related industries. It offers customized research and development services; and develops own technological platforms. The company also provides technological services, including analysis in various scientific areas, pharmaceutical production, cosmetic, and nutraceutics; services of consulting and technical audits; scientific knowledge; and conferences, seminars, workshops, and congresses.

1nKemia IUCT Group, S.A. Fundamentals Summary

How do 1nKemia IUCT Group's earnings and revenue compare to its market cap?
IKM fundamental statistics
Market cap	€8.34m
Earnings (TTM)	-€506.14k
Revenue (TTM)	€42.59k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is IKM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IKM income statement (TTM)
Revenue	€42.59k
Cost of Revenue	-€54.45k
Gross Profit	€97.05k
Other Expenses	€603.19k
Earnings	-€506.14k

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IKM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 19:18
End of Day Share Price	2024/11/15 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

1nKemia IUCT Group, S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

1nKemia IUCT Group, S.A.BME:IKM Stock Report